Pfizer has offered $90 per share in cash for Hospira Photograph: Reuters

Pharmaceutical giant Pfizer has offered to buy Hospira for about $15 billion (€13bn) to boost its portfolio of generic injectible drugs and biosimilar(...)

Gerard Whelan, managing director of Brandcentral

What is unique about your business? My international experience. I’ve done a lot of work in Scandinavia and a global project for Johnson & Johnson(...)

Dozens of cases being taken against the manufacturers of allegedly defective hip replacements may be struck out following a ruling by the High Court.

Dozens of cases being taken against the manufacturers of allegedly defective hip replacements may be struck out following a ruling by the High Court. (...)

Aer Lingus finished down 1.9 per cent at €2.37 during a reasonably active session for the stock

Optimism among investors that the European Central Bank will begin quantitative easing later this week pushed stock prices up to a new seven-year hig(...)

On a high: the continued advance of equities means one influential strategist sees almost no value in the US market and precious little elsewhere.Photograph: Brendan McDermid/Reuters

The US stock market is “hideously expensive,” according to James Montier, an influential strategist with GMO, a global investment management firm bas(...)

Approximately 100 new jobs have been announced in Limerick by a division of medtech giant Johnson & Johnson. Information Technology Shared Service(...)

An Ebola patient arriving at Geneva University Hospital HUG in Geneva, Switzerland on November 21st. Early safety trials for a new vaccine to combat the deadly disease have had encouraging results. Photograph: EPA/Julien Gregorio

An experimental Ebola vaccine caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-(...)

J&J seeks in excess of $5 billion in damages and interest from Boston Scientific, a potentially massive judgment against a company that as of Tuesday had a market capitalisation of $17.8 billion

Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific Corp, Johnson & Johnson finally has a chance for payback (...)

Virgin America president David Cush in the New York Stock Exchange yesterday before the company’s shares’ first day of trading. Photograph: Michael Loccisano/Getty Images

European stocks were little changed as slides in healthcare and commodity stocks offset gains in media companies.Eurostat, the EU’s official number c(...)

World Health Organisation assistant director general Marie Paule Kieny at a news conference on Ebola vaccines in Geneva yesterday.Photograph: Denis Balibouse/Reuters

The World Health Organisation (WHO) set out plans yesterday for speeding up development and deployment of experimental Ebola vaccines, saying hundred(...)